Article
MiR-200c Sensitizes Breast Cancer Cells to Carboplatin Treatment by Decreasing MDR1 Expression
2021-04-26
Abstract excerpt
<title>Abstract</title> <p><bold>Background:</bold> Breast cancer (BC) is one of the most common cancers worldwide and is associated with a high rate of cancer mortality in women. Resistance to chemotherapy is considered a significant problem and a major challenge for the treatment of patients with BC. miR-200c belongs to a family of miRNAs that act as tumor inhibitors. The expression level of miR-200c has been r...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 58105437-5d88-5c2e-be0f-9944ecee1101
- DOI
- 10.21203/rs.3.rs-440566/v1
